This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dynebio Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations by Moon Hee Lee in Sepsis Treatment
Introduction
Moon Hee Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of sepsis and septic shock. His innovative work focuses on utilizing neoagarooligosaccharide as an active ingredient to enhance immune response and suppress inflammation.
Latest Patents
Moon Hee Lee holds 1 patent for his invention titled "Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock." This patent describes a composition that effectively prevents and treats sepsis by leveraging the immune-enhancing properties of neoagarooligosaccharide. The invention demonstrates a promising approach to improving health outcomes for patients at risk of sepsis.
Career Highlights
Moon Hee Lee is associated with Dynebio Inc., where he continues to develop innovative solutions in the healthcare sector. His work is characterized by a commitment to advancing medical science and improving patient care through effective treatments.
Collaborations
He collaborates with talented individuals such as Je Hyeon Lee and Sun Joo Hong, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Moon Hee Lee's contributions to the field of sepsis treatment highlight the importance of innovation in healthcare. His work not only addresses critical medical challenges but also paves the way for future advancements in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile